Jose Arribas

基本信息

浏览量：197

职业迁徙

个人简介

His research interests, which include antiretroviral therapy, development of new antiretrovirals and emerging infectious diseases have driven the publication of over 230 scientific papers. Dr. Arribas is a standing member of GESIDA (Spanish Group for the study of AIDS) and the European AIDS Clinical Society Governing board.

研究兴趣

论文共 529 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Safety of Baricitinib in Vaccinated Patients with Severe and Critical COVID-19. Sub Study of the Randomised Bari-SolidAct Trial

Hans-Kittil Viermyr,Kristian Tonby, Erica Ponzi,Sophie Trouillet-Assant,Julien Poissy,Jose R. Arribas, Virginie Dyon-Tafani,Maude Bouscambert-Duchamp,Lambert Assoumou,Bente Halvorsen, Nuriye Basdag Tekin,Alpha Diallo, Lucie De Gastines,Ludvig A. Munthe,Sarah Louise Murphy,Thor Ueland,Annika E. Michelsen,Fridtjof Lund-Johansen,Pal Aukrust,Joy Mootien, Benjamin Dervieux, Yoann Zerbib, Jean-Christophe Richard, Renaud Prevel, Denis Malvy, Jean-Francois Timsit, Nathan Peiffer-Smadja, Damien Roux, Lionel Piroth, Hafid Ait-Oufella, Cesar Vieira, Olav Dalgard, Lars Heggelund, Karl Erik Muller, Jannicke Horjen Moller, Anders Benjamin Kildal, Vegard Skogen, Saad Aballi, Jonas Daniel Sjoberg Ogaard, Anne Ma Dyrhol-Riise, Anders Tveita, Amin Alirezaylavasani, Dominique Costagliola, Yazdan Yazdanpanah, Inge Christoffer Olsen, Tuva Borresdatter Dahl, Hassen Kared, Aleksander Rygh Holten, Marius Troseid

EBIOMEDICINE（2025）

引用0浏览0WOS引用

Humoral and Cellular Immune Responses after 6 Months of a Heterologous SARS-CoV-2 Booster with the Protein-Based PHH-1V Vaccine in a Phase IIb Trial